Antibiotic growth promoters enhance animal production by targeting intestinal bile salt hydrolase and its producers by Jun Lin
MINI REVIEW ARTICLE
published: 11 February 2014
doi: 10.3389/fmicb.2014.00033
Antibiotic growth promoters enhance animal production by
targeting intestinal bile salt hydrolase and its producers
Jun Lin*
Department of Animal Science, The University of Tennessee, Knoxville, TN, USA
Edited by:
Robert Paul Hunter, Lilly, USA
Reviewed by:
Noton Kumar Dutta, Johns Hopkins
University, USA
Dmitri Debabov, NovaBay
Pharmaceuticals, USA
*Correspondence:
Jun Lin, Department of Animal
Science, The University of Tennessee,
2506 River Drive, Knoxville,
TN 37996-4574, USA
e-mail: jlin6@utk.edu
The growth-promoting effect of antibiotic growth promoters (AGPs) was correlated with the
decreased activity of bile salt hydrolase (BSH), an intestinal bacteria-produced enzyme that
exerts negative impact on host fat digestion and utilization. Consistent with this ﬁnding,
independent chicken studies have demonstrated that AGP usage signiﬁcantly reduced
population of Lactobacillus species, the major BSH-producers in the intestine. Recent
ﬁnding also demonstrated that some AGPs, such as tetracycline and roxarsone, display
direct inhibitory effect on BSH activity. Therefore, BSH is a promising microbiome target
for developing novel alternatives to AGPs. Speciﬁcally, dietary supplementation of BSH
inhibitor may promote host lipid metabolism and energy harvest, consequently enhancing
feed efﬁciency and body weight gain in food animals.
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INTRODUCTION
Epidemiological studies have linked usage of antibiotic growth
promoters (AGPs) to the emergence of antibiotic resistant bacteria
(Wegener, 2003). Antibiotic-resistant bacteria as well as resis-
tance determinants can therefore spread from animals to humans,
compromising the effectiveness of antibiotics for treating human
infections and posing a serious threat to public health (Wegener,
2003). For this reason, Denmark banned all AGPs in 1998
and European Union member nations banned all AGPs in 2006
(Wegener, 2003; Dibner and Richards, 2005). Therefore, there is
a worldwide trend to limit AGP use in food animals (Turnidge,
2004; Dibner and Richards, 2005). Ending the use of AGPs cre-
ates challenges for the animal feed and feed additive industries.
Several products, such as probiotics, prebiotics, and organic acids
have been used to alter intestinal microbiota for improving ani-
mal health and production (Dibner andRichards, 2005). However,
limited data is available to justify the choice of speciﬁc bacterial
species or products for such microbiota manipulation. Examina-
tion of microbiota in response to AGP treatment would provide
insights into the modes of action of AGPs and facilitate the devel-
opment of more effective microbiota-based strategies for growth
promotion. Recent studies on the relationship betweenAGP usage
and gut microbiota strongly suggest that bile salt hydrolase (BSH)
is an important target through which microbiome composition
and function may impact host fat digestion and energy harvest.
RESPONSE OF INTESTINAL BSH ACTIVITY TO AGP
Clearly a connection has been made between AGP usage, growth
promotion, and intestinal bacterial populations, but the precise
mechanism is yet to be delineated as to how these all coincide.
Strides have been made in uncovering this mystery, however,
Abbreviations: AGP, antibiotic growth promoter; BSH, bile salt hydrolase; CBA,
conjugated bile acid.
and it has been shown that the growth-promoting effect of low-
dose antibiotics does coincide with a decrease in BSH activity
in the gut (Feighner and Dashkevicz, 1987; Knarreborg et al.,
2004; Guban et al., 2006). BSH produced by gut bacteria cat-
alyzes deconjugation of conjugated bile acids (CBAs, also referred
to as conjugated bile salts) in the intestine (Begley et al., 2006).
CBAs consist of a hydrophobic steroid core that is conjugated
with either glycine or taurine. Thus, the CBAs are amphipathic
and function as a more efﬁcient “biological detergent” than
unconjugated bile acids to emulsify and solubilize lipids for fat
digestion (Begley et al., 2006). Consequently, BSH activity has sig-
niﬁcant impact on host physiology by disturbing CBA-mediated
fat metabolism and endocrine functions (Begley et al., 2006;
Jones et al., 2008).
Feighner and Dashkevicz (1987) provided early evidence that
antibiotic feed additives affect the transformation potential and
hydrolysis activity of BSHs from intestinal contents of poultry.
By keying in on a more speciﬁc aspect of lipid metabolism,
Knarreborg et al. (2004) demonstrated an enhanced bioavail-
ability of α-tocopheryl (alpha-tocopherol) acetate in broilers
given AGPs, and this was attributed to a reduced concen-
tration of unconjugated bile salts. Furthermore, Guban et al.
(2006) correlated dietary supplementation of AGPs to improved
weight gain and fat digestibility in broilers, decreased popu-
lation levels of Lactobacillus salivarius, and a reduced pool of
deconjugated bile salts. Based on these discoveries, the growth-
promoting effect of AGPs likely is partly attributed to the
reduced BSH activity, and thus the improvement of host lipid
metabolism.
RESPONSE OF INTESTINAL MICROBIOTA TO AGP
With the aid of culture-independent molecular approaches, the
investigations of the effect of AGPs on intestinal microbiota have
been initiated in different food animals, including poultry and
swine, which greatly improves our understanding of intestinal
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microbiota changes in response to AGPs (Engberg et al., 2000;
Knarreborg et al., 2002; Collier et al., 2003; Dumonceaux et al.,
2006; Guban et al., 2006; Wise and Siragusa, 2007; Zhou
et al., 2007; Danzeisen et al., 2011; Kim et al., 2012; Lin et al.,
2013). As expected, oral administration of low-dose antibiotics
affected diversity and relative abundance of gut microbiota in
all these studies. However, based on the ﬁndings from these
molecular ecology studies, it is challenging to deﬁnitively link
speciﬁc bacterial populations to the enhanced growth perfor-
mance due to AGP usage. Interestingly, independent studies
(Engberg et al., 2000; Knarreborg et al., 2002; Dumonceaux
et al., 2006; Guban et al., 2006; Zhou et al., 2007; Danzeisen
et al., 2011; Lin et al., 2013) showed that AGP usage signiﬁ-
cantly reduced the population of Lactobacillus species, a major
bacterial choice for probiotics development; in particular, pop-
ulation of L. salivarius, the dominant lactic acid bacterium
present in the chicken intestine, was reduced in response to
AGP treatment. Since Lactobacillus populations are major BSH-
producers in small intestine (Begley et al., 2006), this inter-
estingly bacterial shift due to AGP usage is consistent with
the reduced BSH activity as described above. Taken together,
these studies indicate that the AGP-mediated body weight gain
in food animal is inversely related to the activity of BSH
enzymes and the abundance of corresponding Lactobacilli pro-
ducers.
CHARACTERISTICS OF BSH
Bacterial BSH is a member of the choloylglycine hydrolase family
of enzymes and is predominantly associated with gastrointestinal
bacteria of both humans and animals. Additionally, it is classiﬁed
as an N-terminal nucleophilic hydrolase and can recognize sub-
strate at both the amino acid conjugate or steroid nucleus (Patel
et al., 2010). BSH is particularly abundant in lactic acid fermenting
probiotic strains like Lactobacilli and Biﬁdobacteria (Begley et al.,
2006). BSH enzymes display either narrow or broad substrate
speciﬁcity; most BSH enzymes from lactic acid bacteria showed
higher catalytic abilities to hydrolyze glyco-CBAs than tauro-CBAs
(Begley et al., 2006). Despite recent signiﬁcant progress in the char-
acterization of diverse BSH enzymes, research on BSH is still in its
infancy (Patel et al., 2010). The natural functions of BSH enzymes
for bacteria themselves are still not clear (Begley et al., 2006). One
hypothesis is that BSH activity confers Lactobacilli tolerance to
bile in the intestine (Begley et al., 2006). However, there are con-
tradictory reports about the correlation between bile tolerance
and BSH activity in intestinal bacteria (Begley et al., 2006). For
example, production of BSH does not determine bile resistance
level in L. salivarius, the dominant Lactobacillus species present
in the chicken intestine (Fang et al., 2009). Regardless the natural
function of BSH for its bacterial producer, it has been increasingly
recognized that intestinal BSH plays an important role in host
lipid metabolism and energy harvest (Begley et al., 2006; Jones
et al., 2008). Recent probiotics studies have already shown that oral
administration of BSH-producing Lactobacilli could affect lipid
metabolism, consequently lowering cholesterol level in humans
(Jones et al., 2012), rats (Kumar et al., 2011), and pigs (De et al.,
1998), which is likelymediated through BSH activity. In the future,
more functional, genomic, andmicrobiological studies are needed
to better understand the role of BSH in the symbiosis relationship
between gut microbiota and host.
PRODUCTION OF BSH BY PROBIOTICS: A NEGATIVE TRAIT FROM
ANIMAL PRODUCTION PERSPECTIVES?
It is no doubt that dietary probiotics, the normal commensal
microorganisms, could exert various beneﬁcial effects on food ani-
mals. However, probiotics do impose a variety of potential costs
(or detrimental effects) to the animal host as well, which include
the production of toxic metabolites, decreased fat digestibility
due to production of BSH, and the increase of mucus secretion
and gut epithelial cell turn-over (Gaskins et al., 2002; Dibner and
Richards, 2004, 2005). Due to such opposite impact of probi-
otics on the host, it is not surprising that inconsistent results
on growth performance of poultry have been observed following
probiotic administration (Perumalla et al., 2011). In particular,
results available from the literature on probiotic treatments often
appear to be contradictory. Lactobacilli have been amajor bacterial
choice for probiotic development in poultry. In general, dietary
probiotic supplementation in chicken increases intestinal pop-
ulations of Lactobacilli (Smirnov et al., 2005). Since Lactobacilli
are dominant BSH-producers in the intestine, dietary Lactobacilli
treatment may negatively affect lipid metabolism and energy har-
vest, consequently imposing negative impact on body weight gain.
Recently, two research groups (Mountzouris et al., 2010; Shariﬁ
et al., 2012) have reported that probiotic supplementation to diets
signiﬁcantly reduced body weight gain, fat digestibility, and feed
conversion in broilers; in these studies, two different commer-
cially available probiotics with a mixture of various organisms
(Protexin and PoultryStar) were used. Based on these ﬁndings,
the authors have proposed that the detrimental effects of the
probiotics on chicken growth are likely attributed to the produc-
tion of intestinal BSH by Lactobacilli (Mountzouris et al., 2010;
Shariﬁ et al., 2012). Therefore, overall beneﬁcial effects associated
with speciﬁc probiotics should be carefully evaluated. Under-
standing the science of potential negative traits of probiotics can
help us develop “negative-traits-mitigation” strategy (e.g., BSH
inhibitors) to optimize probiotic products for enhanced growth
performance of food animals and proﬁtability of feed additive
industry.
DISCOVERY OF BSH INHIBITORS
Based on the information reviewed above, BSH inhibitors are
promising alternatives to AGP for enhanced production of food
animals. This hypothesis has been partly supported by our recent
study (Wang et al., 2012) in which a BSH enzyme with broad
substrate speciﬁcity from a chicken L. salivarius strain was charac-
terized. Examination of a panel of dietary compounds identiﬁed
copper and zinc compounds as potent BSH inhibitor (Wang et al.,
2012); notably, copper and/or zinc have been used at high concen-
trations to aid in feed efﬁciency and growth promotion in poultry
(Ewing et al., 1998; Miles et al., 1998; Arias and Koutsos, 2006) and
swine (Smith et al., 1997; Hill et al., 2000; Armstrong et al., 2004).
However, long-term use of high doses of copper or zinc in animal
feed has raised some serious concerns, such as copper/zinc toxi-
cosis and environmental contamination. Therefore, discovery of
potent, safe, and cost-effective BSH inhibitors is highly warranted.
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In our recent study (Smith et al., 2014), a rapid and convenient
high-throughput screening (HTS) system was developed and has
been successfully used for identiﬁcation of BSH inhibitors. This
HTS strategy is based on the unique feature of BSH enzyme:
hydrolysis of soluble unconjugated bile salts by BSH generates
insoluble unconjugated bile salts that could form signiﬁcant pre-
cipitations (Smith et al., 2014). After optimizing various screening
conditions, a pilot HTS was performed using a small compound
library comprised of 2,240 diverse compounds, leading to the
identiﬁcation of several promising BSH inhibitors with poten-
tial as alternatives to AGPs, such as riboﬂavin and phenethyl
caffeate (Smith et al., 2014). In the future, larger scale HTS
may reveal more novel BSH inhibitors. In addition, compre-
hensive animal trials are needed to determine the effect of
“champion” BSH inhibitors on growth performance of food
animals.
Interestingly, this HTS study also identiﬁed a panel of antibi-
otics as BSH inhibitor, such as various tetracycline antibiotics
and roxarsone that have been widely used as AGPs in food ani-
mals (Smith et al., 2014). This unexpected ﬁnding suggests a new
mode of action of low-dose antibiotics for promoting animal
growth: some AGPs may exert their growth-promoting effect on
food animals by direct inhibition of intestinal BSH enzymes for
enhanced lipid metabolism and energy harvest. However, some
AGPs, such as bacitracin that has been widely used in poul-
try industry (Chapman and Johnson, 2002), only displayed low
or little inhibitory effect on BSH activity (Smith et al., 2014).
The study by Smith et al. (2014) further showed the complex-
ity of the modes of action of AGPs and provided new insights
into the interactions between low-dose antibiotics and gut
microbiome.
CONCLUSIONS AND FUTURE DIRECTIONS
Independent studies have shown the link between usage of AGPs
and reduced BSH activity as well as reduced population of some
Lactobacillus species, the major BSH-producers, in the intestine of
food animals. In light of these ﬁndings, BSH enzyme is a promis-
ing microbiome target for developing novel alternatives to AGPs
for enhancing the productivity and sustainability of food animals.
Recent characterization of a broad-spectrum BSH from L. salivar-
ius (Wang et al., 2012) and development of an efﬁcientHTS system
for discovery of BSH inhibitors (Smith et al., 2014) have laid a solid
foundation for us to develop BSH inhibitors-based feed additives
to replace AGPs. In addition, the ﬁndings from screening of BSH
inhibitors (Smith et al., 2014) suggest a new mode of action of
low-dose antibiotics (direct inhibition of intestinal BSH) for pro-
moting animal growth. In the future, large animal trials are needed
to determine the effects of BSH inhibitors on growth performance
of food animals. Given that research on BSH is still in its infancy,
research on BSH ecology of BSH enzymes in the intestine and
the role of BSH in host physiology is also highly warranted in the
future.
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